Free Trial

OmniAb (OABI) Financials

OmniAb logo
$1.82 -0.03 (-1.62%)
As of 04/24/2025 04:00 PM Eastern
Annual Income Statements for OmniAb

Annual Income Statements for OmniAb

This table shows OmniAb's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
-27 -22 -51 -62
Consolidated Net Income / (Loss)
-27 -22 -51 -62
Net Income / (Loss) Continuing Operations
-27 -22 -51 -62
Total Pre-Tax Income
-34 -26 -64 -71
Total Operating Income
-36 -27 -69 -75
Total Gross Profit
35 59 34 26
Total Revenue
35 59 34 26
Operating Revenue
35 59 34 26
Total Cost of Revenue
0.00 0.00 0.00 0.00
Total Operating Expenses
70 86 104 101
Selling, General & Admin Expense
17 25 33 31
Research & Development Expense
39 48 57 55
Amortization Expense
13 13 14 17
Other Operating Expenses / (Income)
1.21 -0.59 0.19 -2.37
Total Other Income / (Expense), net
1.26 0.59 5.06 3.09
Interest & Investment Income
0.00 0.59 5.06 3.11
Other Income / (Expense), net
1.27 0.00 0.00 -0.02
Income Tax Expense
-7.31 -3.73 -14 -9.38
Basic Earnings per Share
($0.33) ($0.26) ($0.51) ($0.61)
Weighted Average Basic Shares Outstanding
82.61M 85.32M 99.68M 102.37M
Diluted Earnings per Share
($0.33) ($0.26) ($0.51) ($0.61)
Weighted Average Diluted Shares Outstanding
82.61M 85.32M 99.68M 102.37M
Weighted Average Basic & Diluted Shares Outstanding
- 115.58M 117.13M 122.13M

Quarterly Income Statements for OmniAb

This table shows OmniAb's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
-13 6.82 -6.10 -15 -16 -14 -19 -14 -16 -13
Consolidated Net Income / (Loss)
-13 6.82 -6.10 -15 -16 -14 -19 -14 -16 -13
Net Income / (Loss) Continuing Operations
-13 6.82 -6.10 -15 -16 -14 -19 -14 -16 -13
Total Pre-Tax Income
-15 9.64 -7.13 -18 -19 -20 -22 -16 -19 -15
Total Operating Income
-15 9.05 -8.45 -19 -20 -21 -23 -16 -20 -16
Total Gross Profit
6.91 35 17 6.95 5.48 4.82 3.80 7.61 4.17 11
Total Revenue
6.91 35 17 6.95 5.48 4.82 3.80 7.61 4.17 11
Operating Revenue
6.91 35 17 6.95 5.48 4.82 3.80 7.61 4.17 11
Total Operating Expenses
22 26 25 26 26 26 26 24 24 27
Selling, General & Admin Expense
5.58 10 8.20 8.74 8.51 7.87 8.34 7.97 7.08 7.36
Research & Development Expense
13 13 14 14 14 15 15 14 13 13
Amortization Expense
3.26 3.28 3.37 3.38 3.40 3.41 3.41 4.54 3.39 6.06
Other Operating Expenses / (Income)
-0.21 -0.11 0.05 0.14 0.02 -0.01 0.05 -2.52 0.15 -0.04
Total Other Income / (Expense), net
0.00 0.59 1.32 1.28 1.27 1.18 0.98 0.78 0.68 0.66
Interest & Investment Income
0.00 0.59 1.32 1.29 1.27 1.18 0.98 0.79 0.69 0.66
Income Tax Expense
-2.31 2.82 -1.03 -3.44 -3.30 -5.98 -2.62 -1.90 -2.71 -2.16
Basic Earnings per Share
($0.15) $0.09 ($0.06) ($0.15) ($0.16) ($0.14) ($0.19) ($0.13) ($0.16) ($0.13)
Weighted Average Basic Shares Outstanding
82.61M 85.32M 99.16M 99.49M 99.91M 99.68M 100.76M 101.46M 102.39M 102.37M
Diluted Earnings per Share
($0.15) $0.09 ($0.06) ($0.15) ($0.16) ($0.14) ($0.19) ($0.13) ($0.16) ($0.13)
Weighted Average Diluted Shares Outstanding
82.61M 85.32M 99.16M 99.49M 99.91M 99.68M 100.76M 101.46M 102.39M 102.37M
Weighted Average Basic & Diluted Shares Outstanding
0.00 115.58M 115.60M 116.17M 116.24M 117.13M 117.62M 118.16M 121.01M 122.13M

Annual Cash Flow Statements for OmniAb

This table details how cash moves in and out of OmniAb's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Net Change in Cash & Equivalents
0.00 34 -17 11
Net Cash From Operating Activities
-5.67 -3.59 2.35 -40
Net Cash From Continuing Operating Activities
-5.67 -3.59 2.35 -40
Net Income / (Loss) Continuing Operations
-27 -22 -51 -62
Consolidated Net Income / (Loss)
-27 -22 -51 -62
Depreciation Expense
16 18 19 24
Amortization Expense
- -0.17 -3.44 -1.50
Non-Cash Adjustments To Reconcile Net Income
14 19 25 22
Changes in Operating Assets and Liabilities, net
-8.75 -18 12 -22
Net Cash From Investing Activities
-4.03 -73 -18 38
Net Cash From Continuing Investing Activities
-4.03 -73 -18 38
Purchase of Property, Plant & Equipment
-4.07 -17 -1.64 -1.88
Purchase of Investments
0.00 -55 -113 -40
Sale and/or Maturity of Investments
1.27 0.07 100 80
Other Investing Activities, net
-1.22 -1.44 -4.44 -0.40
Net Cash From Financing Activities
9.70 111 -0.89 13
Net Cash From Continuing Financing Activities
9.70 111 -0.89 13
Issuance of Common Equity
0.00 97 1.21 15
Other Financing Activities, net
9.70 14 -2.10 -1.61
Cash Income Taxes Paid
- 0.00 2.61 0.02

Quarterly Cash Flow Statements for OmniAb

This table details how cash moves in and out of OmniAb's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
- 34 -11 -1.76 0.26 -4.89 2.70 1.73 6.44 0.36
Net Cash From Operating Activities
-4.23 -7.14 28 -10 -6.20 -9.12 -17 -12 -6.58 -3.87
Net Cash From Continuing Operating Activities
-4.23 -7.14 28 -10 -6.20 -9.12 -17 -12 -6.58 -3.87
Net Income / (Loss) Continuing Operations
-13 6.82 -6.10 -15 -16 -14 -19 -14 -16 -13
Consolidated Net Income / (Loss)
-13 6.82 -6.10 -15 -16 -14 -19 -14 -16 -13
Depreciation Expense
4.50 4.82 4.86 4.86 4.84 4.93 4.95 6.10 4.93 7.61
Amortization Expense
- -0.17 -0.93 -0.89 -0.83 -0.79 -0.62 -0.38 -0.29 -0.21
Non-Cash Adjustments To Reconcile Net Income
5.11 6.37 6.03 7.09 5.86 5.94 5.68 5.93 5.30 5.14
Changes in Operating Assets and Liabilities, net
-1.25 -25 24 -6.36 -0.34 -5.15 -8.08 -10 -0.14 -3.33
Net Cash From Investing Activities
-4.88 -60 -37 7.78 6.29 4.73 20 13 4.45 0.39
Net Cash From Continuing Investing Activities
-4.88 -60 -37 7.78 6.29 4.73 20 13 4.45 0.39
Purchase of Property, Plant & Equipment
-3.92 -5.02 -0.23 -0.81 -0.49 -0.11 -0.93 -0.75 -0.15 -0.05
Purchase of Investments
- -55 -39 -17 -31 -26 -5.42 -11 -8.98 -15
Sale and/or Maturity of Investments
- 0.07 4.21 26 38 31 27 25 14 15
Net Cash From Financing Activities
9.11 101 -1.05 0.48 0.17 -0.50 -0.20 0.80 8.57 3.85
Net Cash From Continuing Financing Activities
9.11 101 -1.05 0.48 0.17 -0.50 -0.20 0.80 8.57 3.85
Issuance of Common Equity
- 97 0.19 0.62 0.19 0.22 1.00 1.14 8.59 3.90
Other Financing Activities, net
9.11 4.32 -1.23 -0.14 -0.02 -0.71 -1.21 -0.34 -0.02 -0.05

Annual Balance Sheets for OmniAb

This table presents OmniAb's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Total Assets
304 421 375 326
Total Current Assets
23 125 95 68
Cash & Equivalents
0.00 33 16 28
Short-Term Investments
0.00 55 71 32
Accounts Receivable
21 30 3.84 5.27
Prepaid Expenses
1.41 6.40 4.07 3.43
Plant, Property, & Equipment, net
6.80 20 18 15
Total Noncurrent Assets
275 276 262 242
Goodwill
84 84 84 84
Intangible Assets
176 167 155 138
Other Noncurrent Operating Assets
15 25 23 20
Total Liabilities & Shareholders' Equity
304 421 375 326
Total Liabilities
70 80 61 38
Total Current Liabilities
21 26 23 15
Short-Term Debt
2.54 4.02 1.30 0.53
Accounts Payable
2.92 2.97 4.41 2.30
Accrued Expenses
3.75 5.56 7.07 6.14
Current Deferred Revenue
11 8.21 6.85 2.34
Other Current Liabilities
0.58 1.78 3.49 3.78
Total Noncurrent Liabilities
50 54 38 23
Capital Lease Obligations
13 24 22 19
Noncurrent Deferred Revenue
9.23 4.33 0.86 0.12
Noncurrent Deferred & Payable Income Tax Liabilities
22 21 11 2.31
Other Noncurrent Operating Liabilities
5.12 4.14 3.23 1.04
Commitments & Contingencies
- 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
234 341 315 288
Total Preferred & Common Equity
234 341 315 288
Preferred Stock
0.00 0.00 0.00 0.00
Total Common Equity
234 341 315 288
Common Stock
0.00 330 354 389
Retained Earnings
0.00 11 -39 -101
Accumulated Other Comprehensive Income / (Loss)
0.00 0.01 0.05 0.03

Quarterly Balance Sheets for OmniAb

This table presents OmniAb's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
238 413 405 392 353 337 332
Total Current Assets
0.42 121 116 107 77 67 67
Cash & Equivalents
0.02 23 21 21 19 21 27
Short-Term Investments
- 91 82 75 50 36 32
Accounts Receivable
- 1.82 8.61 6.14 4.05 6.88 3.50
Prepaid Expenses
0.40 5.66 4.18 4.08 3.67 3.20 3.73
Plant, Property, & Equipment, net
0.00 19 19 19 18 17 16
Total Noncurrent Assets
237 273 270 266 258 253 249
Goodwill
- 84 84 84 84 84 84
Intangible Assets
- 164 162 159 152 148 144
Other Noncurrent Operating Assets
237 24 24 24 22 21 21
Total Liabilities & Shareholders' Equity
238 413 405 392 353 337 332
Total Liabilities
14 72 71 67 51 43 40
Total Current Liabilities
10 22 24 25 18 14 14
Short-Term Debt
- 2.47 2.81 1.75 0.89 0.33 0.51
Accounts Payable
6.39 2.49 2.36 2.50 3.56 2.81 2.19
Accrued Expenses
1.53 3.91 4.93 6.52 4.03 4.55 5.45
Current Deferred Revenue
- 6.89 7.27 7.38 5.53 2.91 2.51
Other Current Liabilities
2.35 2.44 3.42 3.45 3.52 3.56 3.75
Total Noncurrent Liabilities
4.03 51 47 42 34 29 25
Capital Lease Obligations
- 23 23 23 21 21 20
Noncurrent Deferred Revenue
- 3.02 3.48 1.95 0.28 0.07 0.04
Noncurrent Deferred & Payable Income Tax Liabilities
- 20 17 14 8.74 6.84 4.13
Other Noncurrent Operating Liabilities
4.03 3.73 3.42 3.56 3.21 1.24 1.16
Total Equity & Noncontrolling Interests
-14 341 334 325 301 294 292
Total Preferred & Common Equity
-14 341 334 325 301 294 292
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-14 341 334 325 301 294 292
Common Stock
0.00 336 343 350 360 366 380
Retained Earnings
-14 5.15 -9.58 -25 -58 -72 -88
Accumulated Other Comprehensive Income / (Loss)
- 0.01 -0.05 -0.05 -0.02 -0.03 0.05

Annual Metrics and Ratios for OmniAb

This table displays calculated financial ratios and metrics derived from OmniAb's official financial filings.

Metric 2021 2022 2023 2024
Growth Metrics
- - - -
Revenue Growth
0.00% 70.02% -42.17% -22.75%
EBITDA Growth
0.00% 52.63% -522.73% 1.74%
EBIT Growth
0.00% 22.41% -160.50% -7.35%
NOPAT Growth
0.00% 25.17% -160.50% -7.32%
Net Income Growth
0.00% 17.41% -126.65% -22.55%
EPS Growth
0.00% 21.21% -96.15% -19.61%
Operating Cash Flow Growth
0.00% 36.76% 165.43% -1,789.99%
Free Cash Flow Firm Growth
0.00% 0.00% 61.66% -161.01%
Invested Capital Growth
0.00% 12.23% -10.59% -1.15%
Revenue Q/Q Growth
0.00% 0.00% -47.19% 29.31%
EBITDA Q/Q Growth
0.00% 0.00% -136.10% 14.03%
EBIT Q/Q Growth
0.00% 0.00% -77.25% 6.65%
NOPAT Q/Q Growth
0.00% 0.00% -77.26% 6.67%
Net Income Q/Q Growth
0.00% 0.00% -70.17% 1.56%
EPS Q/Q Growth
0.00% 0.00% -82.14% 1.61%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -45.73% 11.69%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 12.69%
Invested Capital Q/Q Growth
0.00% 0.00% -0.56% -1.92%
Profitability Metrics
- - - -
Gross Margin
100.00% 100.00% 100.00% 100.00%
EBITDA Margin
-52.06% -14.50% -156.19% -198.67%
Operating Margin
-102.48% -45.11% -203.19% -282.30%
EBIT Margin
-98.83% -45.11% -203.19% -282.36%
Profit (Net Income) Margin
-77.82% -37.80% -148.16% -235.05%
Tax Burden Percent
78.72% 85.70% 78.65% 86.87%
Interest Burden Percent
100.02% 97.80% 92.72% 95.83%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-9.97% -7.03% -18.28% -20.90%
ROIC Less NNEP Spread (ROIC-NNEP)
-23.35% 9.38% -15.02% -1.74%
Return on Net Nonoperating Assets (RNNOA)
-1.58% -0.73% 2.85% 0.30%
Return on Equity (ROE)
-11.54% -7.76% -15.43% -20.60%
Cash Return on Invested Capital (CROIC)
0.00% -18.55% -7.10% -19.74%
Operating Return on Assets (OROA)
-11.28% -7.34% -17.43% -21.27%
Return on Assets (ROA)
-8.88% -6.16% -12.71% -17.70%
Return on Common Equity (ROCE)
-11.54% -7.76% -15.43% -20.60%
Return on Equity Simple (ROE_SIMPLE)
-11.54% -6.54% -16.09% -21.57%
Net Operating Profit after Tax (NOPAT)
-25 -19 -49 -52
NOPAT Margin
-71.73% -31.58% -142.24% -197.61%
Net Nonoperating Expense Percent (NNEP)
13.38% -16.41% -3.26% -19.16%
Return On Investment Capital (ROIC_SIMPLE)
- - -14.38% -16.96%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
48.77% 42.15% 97.51% 116.48%
R&D to Revenue
112.90% 81.87% 165.45% 208.82%
Operating Expenses to Revenue
202.48% 145.11% 303.19% 382.30%
Earnings before Interest and Taxes (EBIT)
-34 -27 -69 -75
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-18 -8.57 -53 -52
Valuation Ratios
- - - -
Price to Book Value (P/BV)
0.00 0.30 2.28 1.49
Price to Tangible Book Value (P/TBV)
0.00 1.15 9.55 6.53
Price to Revenue (P/Rev)
0.00 1.75 20.99 16.23
Price to Earnings (P/E)
0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.15 2.60 1.57
Enterprise Value to Revenue (EV/Rev)
0.00 0.73 19.13 14.73
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 278.48 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00
Leverage & Solvency
- - - -
Debt to Equity
0.07 0.08 0.07 0.07
Long-Term Debt to Equity
0.06 0.07 0.07 0.07
Financial Leverage
0.07 -0.08 -0.19 -0.17
Leverage Ratio
1.30 1.26 1.21 1.16
Compound Leverage Factor
1.30 1.23 1.13 1.12
Debt to Total Capital
6.32% 7.59% 6.92% 6.48%
Short-Term Debt to Total Capital
1.01% 1.09% 0.39% 0.17%
Long-Term Debt to Total Capital
5.31% 6.50% 6.53% 6.30%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
93.68% 92.41% 93.08% 93.52%
Debt to EBITDA
-0.87 -3.27 -0.44 -0.38
Net Debt to EBITDA
-0.87 7.03 1.19 0.75
Long-Term Debt to EBITDA
-0.73 -2.80 -0.41 -0.37
Debt to NOPAT
-0.63 -1.50 -0.48 -0.38
Net Debt to NOPAT
-0.63 3.23 1.31 0.76
Long-Term Debt to NOPAT
-0.53 -1.29 -0.45 -0.37
Altman Z-Score
0.00 1.03 6.66 5.86
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - -
Current Ratio
1.10 4.80 4.11 4.52
Quick Ratio
1.03 4.56 3.93 4.29
Cash Flow Metrics
- - - -
Free Cash Flow to Firm (FCFF)
0.00 -49 -19 -49
Operating Cash Flow to CapEx
-139.36% -20.89% 142.76% -2,115.41%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
-810.29 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-1,391.71 0.00 0.00 0.00
Efficiency Ratios
- - - -
Asset Turnover
0.11 0.16 0.09 0.08
Accounts Receivable Turnover
1.64 2.30 2.00 5.79
Inventory Turnover
0.00 0.00 0.00 0.00
Fixed Asset Turnover
5.11 4.41 1.79 1.56
Accounts Payable Turnover
0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
222.02 158.86 182.34 63.04
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
222.02 158.86 182.34 63.04
Capital & Investment Metrics
- - - -
Invested Capital
250 281 251 248
Invested Capital Turnover
0.14 0.22 0.13 0.11
Increase / (Decrease) in Invested Capital
0.00 31 -30 -2.88
Enterprise Value (EV)
0.00 43 654 389
Market Capitalization
0.00 104 717 428
Book Value per Share
$8.15 $4.00 $2.71 $2.38
Tangible Book Value per Share
($0.90) $1.06 $0.65 $0.54
Total Capital
250 369 338 308
Total Debt
16 28 23 20
Total Long-Term Debt
13 24 22 19
Net Debt
16 -60 -64 -40
Capital Expenditures (CapEx)
4.07 17 1.64 1.88
Debt-free, Cash-free Net Working Capital (DFCFNWC)
4.50 15 -14 -5.85
Debt-free Net Working Capital (DFNWC)
4.50 103 73 54
Net Working Capital (NWC)
1.97 99 72 53
Net Nonoperating Expense (NNE)
2.12 3.68 2.03 9.88
Net Nonoperating Obligations (NNO)
16 -61 -64 -40
Total Depreciation and Amortization (D&A)
16 18 16 22
Debt-free, Cash-free Net Working Capital to Revenue
12.96% 24.86% -40.67% -22.18%
Debt-free Net Working Capital to Revenue
12.96% 174.26% 213.93% 203.03%
Net Working Capital to Revenue
5.66% 167.46% 210.12% 201.02%
Earnings Adjustments
- - - -
Adjusted Basic Earnings per Share
$0.00 ($0.26) ($0.51) ($0.61)
Adjusted Weighted Average Basic Shares Outstanding
0.00 85.32M 99.68M 102.37M
Adjusted Diluted Earnings per Share
$0.00 ($0.26) ($0.51) ($0.61)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 85.32M 99.68M 102.37M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 115.58M 117.13M 122.13M
Normalized Net Operating Profit after Tax (NOPAT)
-25 -19 -49 -52
Normalized NOPAT Margin
-71.73% -31.58% -142.24% -197.61%
Pre Tax Income Margin
-98.85% -44.11% -188.39% -270.59%
Debt Service Ratios
- - - -
EBIT to Interest Expense
-4,906.14 0.00 0.00 0.00
NOPAT to Interest Expense
-3,560.90 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-5,487.57 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-4,142.33 0.00 0.00 0.00
Payout Ratios
- - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for OmniAb

This table displays calculated financial ratios and metrics derived from OmniAb's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
0.00% 0.00% 75.82% -3.51% -20.74% -86.36% -77.53% 9.62% -23.83% 124.06%
EBITDA Growth
-6,000.99% 0.00% -19.60% -91.64% -56.54% -224.54% -302.61% 31.58% 7.12% 50.26%
EBIT Growth
-8,640.23% 0.00% -2.80% -54.77% -36.21% -334.32% -166.80% 16.12% 2.63% 25.12%
NOPAT Growth
-8,640.23% 0.00% -2.80% -54.74% -36.26% -331.77% -166.80% 16.15% 2.71% 25.12%
Net Income Growth
-7,284.26% 0.00% 2.90% -43.32% -24.94% -306.06% -210.84% 7.45% -4.03% 7.01%
EPS Growth
0.00% 0.00% 25.00% -25.00% -6.67% -255.56% -216.67% 13.33% 0.00% 7.14%
Operating Cash Flow Growth
0.00% 0.00% 137.87% -160.18% -46.46% -27.69% -161.51% -21.55% -6.13% 57.55%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 78.92% -785.77% 0.00% 51.75% 73.44% 66.80% -155.36%
Invested Capital Growth
-2.42% 0.00% 13.52% 15.78% 13.03% -10.59% 0.64% 0.58% 0.22% -1.15%
Revenue Q/Q Growth
-4.01% 411.51% -52.13% -58.95% -21.15% -11.96% -21.17% 100.32% -45.21% 158.96%
EBITDA Q/Q Growth
-28.85% 231.64% -133.04% -241.93% -5.25% -4.73% -6.82% 41.90% -42.88% 43.91%
EBIT Q/Q Growth
-18.65% 160.70% -193.40% -130.08% -4.41% -4.43% -6.35% 27.66% -21.20% 19.68%
NOPAT Q/Q Growth
-18.65% 161.37% -192.39% -130.04% -4.47% -4.39% -6.35% 27.70% -21.21% 19.65%
Net Income Q/Q Growth
-22.58% 154.14% -189.44% -141.44% -6.86% 10.71% -34.92% 28.11% -20.12% 20.19%
EPS Q/Q Growth
-25.00% 160.00% -166.67% -150.00% -6.67% 12.50% -35.71% 31.58% -23.08% 18.75%
Operating Cash Flow Q/Q Growth
-9.87% -68.79% 487.62% -136.20% 38.16% -47.16% -86.73% 28.48% 46.00% 41.14%
Free Cash Flow Firm Q/Q Growth
97.88% 100.00% 0.00% -34.74% 10.82% 134.33% -216.97% 25.83% -11.46% 42.75%
Invested Capital Q/Q Growth
0.77% 25.70% -9.84% 1.38% -1.62% -0.56% 1.48% 1.32% -1.98% -1.92%
Profitability Metrics
- - - - - - - - - -
Gross Margin
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin
-150.61% 38.76% -26.76% -222.85% -297.44% -353.84% -479.51% -139.09% -362.68% -78.55%
Operating Margin
-215.76% 25.60% -49.96% -279.95% -370.91% -439.78% -593.34% -214.15% -473.73% -146.98%
EBIT Margin
-215.76% 25.60% -49.96% -280.00% -370.77% -439.78% -593.34% -214.26% -473.92% -146.98%
Profit (Net Income) Margin
-182.29% 19.30% -36.05% -212.04% -287.35% -291.44% -498.84% -179.03% -392.45% -120.96%
Tax Burden Percent
84.49% 70.77% 85.57% 81.08% 82.65% 70.17% 87.87% 87.78% 85.81% 85.84%
Interest Burden Percent
100.00% 106.49% 84.34% 93.39% 93.77% 94.45% 95.68% 95.19% 96.51% 95.86%
Effective Tax Rate
0.00% 29.23% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 3.81% -9.75% -54.19% -70.61% -39.56% -34.43% -12.65% -26.79% -10.88%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 3.13% -9.34% -51.31% -66.41% -40.84% -29.71% -8.74% -22.21% -7.10%
Return on Net Nonoperating Assets (RNNOA)
0.00% -0.56% 1.46% 7.15% 8.75% 7.74% 6.22% 1.58% 4.00% 1.22%
Return on Equity (ROE)
0.00% 3.26% -8.29% -47.05% -61.87% -31.83% -28.21% -11.07% -22.79% -9.67%
Cash Return on Invested Capital (CROIC)
0.00% -17.54% 0.00% 0.00% 0.00% -7.10% -23.66% -22.45% -22.33% -19.74%
Operating Return on Assets (OROA)
0.00% 4.17% -10.20% -57.67% -76.22% -37.73% -32.62% -12.53% -26.75% -11.07%
Return on Assets (ROA)
0.00% 3.14% -7.36% -43.67% -59.07% -25.00% -27.43% -10.47% -22.15% -9.11%
Return on Common Equity (ROCE)
0.00% 3.26% -4.83% -27.05% -35.08% -31.82% -28.21% -11.07% -22.79% -9.67%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% -6.50% -7.97% -9.17% 0.00% -21.06% -21.21% -21.60% 0.00%
Net Operating Profit after Tax (NOPAT)
-10 6.40 -5.92 -14 -14 -15 -16 -11 -14 -11
NOPAT Margin
-151.03% 18.12% -34.97% -195.96% -259.64% -307.84% -415.34% -149.90% -331.61% -102.89%
Net Nonoperating Expense Percent (NNEP)
-21,763.49% 0.68% -0.42% -2.89% -4.21% 1.27% -4.72% -3.91% -4.58% -3.79%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - -4.39% - - - -3.61%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
80.78% 28.88% 48.44% 125.80% 155.40% 163.19% 219.34% 104.61% 169.68% 68.12%
R&D to Revenue
190.87% 36.55% 81.32% 203.47% 253.19% 306.22% 382.82% 183.02% 319.22% 123.16%
Operating Expenses to Revenue
315.76% 74.40% 149.96% 379.95% 470.91% 539.78% 693.34% 314.15% 573.73% 246.98%
Earnings before Interest and Taxes (EBIT)
-15 9.05 -8.45 -19 -20 -21 -23 -16 -20 -16
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-10 14 -4.53 -15 -16 -17 -18 -11 -15 -8.49
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.30 1.25 1.74 1.86 2.28 2.11 1.50 1.71 1.49
Price to Tangible Book Value (P/TBV)
0.00 1.15 4.60 6.61 7.37 9.55 9.71 7.04 7.86 6.53
Price to Revenue (P/Rev)
0.00 1.75 6.41 8.79 9.32 20.99 30.16 20.31 24.49 16.23
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.15 1.33 1.97 2.10 2.60 2.31 1.57 1.82 1.57
Enterprise Value to Revenue (EV/Rev)
0.00 0.73 5.09 7.63 8.21 19.13 27.94 18.65 22.59 14.73
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 27.10 80.15 122.72 278.48 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.08 0.08 0.08 0.08 0.07 0.07 0.07 0.07 0.07
Long-Term Debt to Equity
0.00 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07
Financial Leverage
0.00 -0.18 -0.16 -0.14 -0.13 -0.19 -0.21 -0.18 -0.18 -0.17
Leverage Ratio
1.05 1.26 1.15 1.16 1.15 1.21 1.19 1.18 1.17 1.16
Compound Leverage Factor
1.05 1.34 0.97 1.08 1.08 1.15 1.14 1.13 1.13 1.12
Debt to Total Capital
0.00% 7.59% 7.06% 7.20% 7.01% 6.92% 6.89% 6.69% 6.60% 6.48%
Short-Term Debt to Total Capital
0.00% 1.09% 0.67% 0.78% 0.50% 0.39% 0.28% 0.10% 0.16% 0.17%
Long-Term Debt to Total Capital
0.00% 6.50% 6.39% 6.42% 6.51% 6.53% 6.62% 6.59% 6.43% 6.30%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
106.21% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
-6.21% 92.41% 92.94% 92.80% 92.99% 93.08% 93.11% 93.30% 93.40% 93.52%
Debt to EBITDA
0.00 -3.27 -2.78 -1.55 -1.08 -0.44 -0.33 -0.34 -0.34 -0.38
Net Debt to EBITDA
0.00 7.03 9.42 4.62 3.19 1.19 0.70 0.58 0.64 0.75
Long-Term Debt to EBITDA
0.00 -2.80 -2.52 -1.38 -1.01 -0.41 -0.32 -0.33 -0.33 -0.37
Debt to NOPAT
0.00 -1.50 -1.38 -1.10 -0.89 -0.48 -0.38 -0.38 -0.37 -0.38
Net Debt to NOPAT
0.00 3.23 4.66 3.27 2.63 1.31 0.80 0.64 0.69 0.76
Long-Term Debt to NOPAT
0.00 -1.29 -1.24 -0.98 -0.83 -0.45 -0.37 -0.37 -0.36 -0.37
Altman Z-Score
0.00 1.31 3.93 5.13 5.54 7.08 7.26 5.94 7.21 6.45
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 41.79% 42.50% 43.29% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
0.04 4.80 5.59 4.78 4.26 4.11 4.38 4.76 4.63 4.52
Quick Ratio
0.00 4.56 5.32 4.61 4.10 3.93 4.17 4.53 4.37 4.29
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-4.89 0.00 -36 -49 -43 15 -17 -13 -14 -8.23
Operating Cash Flow to CapEx
-108.10% -142.40% 11,832.48% -1,232.72% -1,264.90% -8,524.30% -1,839.31% -1,622.10% -4,327.63% -8,417.39%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.00 0.16 0.20 0.21 0.21 0.09 0.06 0.06 0.06 0.08
Accounts Receivable Turnover
0.00 2.30 0.00 0.00 0.00 2.00 7.18 2.80 4.24 5.79
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 4.41 0.00 0.00 0.00 1.79 1.13 1.19 1.17 1.56
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 158.86 0.00 0.00 0.00 182.34 50.85 130.16 86.13 63.04
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 158.86 0.00 0.00 0.00 182.34 50.85 130.16 86.13 63.04
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
223 281 253 257 252 251 255 258 253 248
Invested Capital Turnover
0.00 0.21 0.28 0.28 0.27 0.13 0.08 0.08 0.08 0.11
Increase / (Decrease) in Invested Capital
-5.55 0.00 30 35 29 -30 1.61 1.49 0.55 -2.88
Enterprise Value (EV)
0.00 43 338 504 531 654 588 405 461 389
Market Capitalization
0.00 104 425 581 603 717 635 441 500 428
Book Value per Share
($0.48) $4.00 $2.95 $2.89 $2.79 $2.71 $2.57 $2.50 $2.47 $2.38
Tangible Book Value per Share
($0.48) $1.06 $0.80 $0.76 $0.70 $0.65 $0.56 $0.53 $0.54 $0.54
Total Capital
223 369 367 360 349 338 324 315 312 308
Total Debt
0.00 28 26 26 24 23 22 21 21 20
Total Long-Term Debt
0.00 24 23 23 23 22 21 21 20 19
Net Debt
-0.02 -60 -88 -77 -72 -64 -47 -36 -39 -40
Capital Expenditures (CapEx)
3.92 5.02 0.23 0.81 0.49 0.11 0.93 0.75 0.15 0.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-9.86 15 -12 -8.64 -13 -14 -8.92 -3.75 -6.66 -5.85
Debt-free Net Working Capital (DFNWC)
-9.84 103 102 95 84 73 60 53 53 54
Net Working Capital (NWC)
-9.84 99 99 92 82 72 59 53 52 53
Net Nonoperating Expense (NNE)
2.16 -0.42 0.18 1.12 1.52 -0.79 3.17 2.22 2.54 1.95
Net Nonoperating Obligations (NNO)
-0.02 -61 -88 -77 -72 -64 -47 -36 -39 -40
Total Depreciation and Amortization (D&A)
4.50 4.65 3.93 3.97 4.02 4.14 4.33 5.72 4.64 7.39
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 24.86% -17.67% -13.07% -20.23% -40.67% -42.38% -17.27% -32.65% -22.18%
Debt-free Net Working Capital to Revenue
0.00% 174.26% 153.49% 142.94% 129.15% 213.93% 285.51% 246.27% 258.30% 203.03%
Net Working Capital to Revenue
0.00% 167.46% 149.77% 138.69% 126.44% 210.12% 281.27% 244.76% 255.80% 201.02%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($0.18) $0.09 ($0.06) ($0.15) ($0.16) ($0.14) ($0.19) ($0.13) ($0.16) ($0.13)
Adjusted Weighted Average Basic Shares Outstanding
28.75M 85.32M 99.16M 99.49M 99.91M 99.68M 100.76M 101.46M 102.39M 102.37M
Adjusted Diluted Earnings per Share
($0.18) $0.09 ($0.06) ($0.15) ($0.16) ($0.14) ($0.19) ($0.13) ($0.16) ($0.13)
Adjusted Weighted Average Diluted Shares Outstanding
28.75M 85.32M 99.16M 99.49M 99.91M 99.68M 100.76M 101.46M 102.39M 102.37M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 115.58M 115.60M 116.17M 116.24M 117.13M 117.62M 118.16M 121.01M 122.13M
Normalized Net Operating Profit after Tax (NOPAT)
-10 6.40 -5.92 -14 -14 -15 -16 -11 -14 -11
Normalized NOPAT Margin
-151.03% 18.12% -34.97% -195.96% -259.64% -307.84% -415.34% -149.90% -331.61% -102.89%
Pre Tax Income Margin
-215.76% 27.27% -42.14% -261.50% -347.67% -415.35% -567.69% -203.95% -457.36% -140.90%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About OmniAb's Financials

When does OmniAb's fiscal year end?

According to the most recent income statement we have on file, OmniAb's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has OmniAb's net income changed over the last 3 years?

OmniAb's net income appears to be on an upward trend, with a most recent value of -$62.03 million in 2024, rising from -$27.04 million in 2021. The previous period was -$50.62 million in 2023.

What is OmniAb's operating income?
OmniAb's total operating income in 2024 was -$74.50 million, based on the following breakdown:
  • Total Gross Profit: $26.39 million
  • Total Operating Expenses: $100.89 million
How has OmniAb revenue changed over the last 3 years?

Over the last 3 years, OmniAb's total revenue changed from $34.75 million in 2021 to $26.39 million in 2024, a change of -24.1%.

How much debt does OmniAb have?

OmniAb's total liabilities were at $37.94 million at the end of 2024, a 37.4% decrease from 2023, and a 45.9% decrease since 2021.

How much cash does OmniAb have?

In the past 3 years, OmniAb's cash and equivalents has ranged from $0.00 in 2021 to $33.39 million in 2022, and is currently $27.60 million as of their latest financial filing in 2024.

How has OmniAb's book value per share changed over the last 3 years?

Over the last 3 years, OmniAb's book value per share changed from 8.15 in 2021 to 2.38 in 2024, a change of -70.8%.



This page (NASDAQ:OABI) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners